Skip to main content
Back to Mitsubishi UFJ Capital

Mitsubishi UFJ Capital's Therapeutics Portfolio

Browse 8 Therapeutics companies funded by Mitsubishi UFJ Capital. See funding amounts, founder contacts, and investment details.

Therapeutics Companies
8
Total Funding in Therapeutics
$216.6M

Therapeutics Portfolio Companies (8)

Export
Addiction TreatmentHealth CareMedicalMobile AppsSoftwareTherapeutics

CureApp is a digital health and therapeutic medical device software that connects patients and doctors.

Tokyo, Japan
August 2022
$52.1M
Series G

Founder Contacts

30,000+ verified contacts

Health CareMedicalMedical DeviceTherapeutics

Save Medical has been promoting the design and development of DTx and SaMD through partnerships with other companies.

Tokyo, Japan
July 2021
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsTherapeutics

Neusignal Therapeutics is a medical company that develops therapeutic medicines for dementia and psychiatric illnesses.

Tokyo, Japan
June 2026
$32.8M
Series B

Founder Contacts

30,000+ verified contacts

Alternative MedicinePersonal HealthTherapeutics

Periotherapia is a drug discovery business with triple negative breast cancer as the first indication.

Osaka, Japan
May 2026
$6.8M
Grant

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CareHealth DiagnosticsLife ScienceMedicalTherapeutics

Numab is a biotechnology company that offers antibody-based therapeutics for the treatment of severe diseases.

Wadenswil, Switzerland
January 2025
$54.9M
Series C

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyPharmaceuticalTherapeutics

RadioNano Therapeutics is a medical technology company that develops radiation therapy solutions for the treatment of cancer patients.

Kyoto, Japan
December 2024
$955K
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Shinobi Therapeutics develops immune-evasive iPS cell therapies for cancer treatment.

South San Francisco, United States
August 2024
$68.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalPrecision MedicineProduct ResearchTherapeutics

Luxana Biotech is a biotechnology firm aimed at developing nucleic acid drugs to enhance medical treatment for patients in need.

Osaka, Japan
August 2025
$1.0M
Series C

Founder Contacts

30,000+ verified contacts

Explore Mitsubishi UFJ Capital's Full Portfolio

View all companies funded by Mitsubishi UFJ Capital across every industry and funding stage.

View Full Mitsubishi UFJ Capital Portfolio